Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Labeling Standards Top Kennedy’s Agenda For Commissioner Nominee

Oct 14 2002

• By The Pink Sheet

Related Content

FDA Generic Biologics Policy May Be One Change Under McClellan

Oct 14 2002

PDUFA III Includes Risk Management Fees For “Peri-Approval” Phase

Mar 11 2002

Rx Labeling Should Be Left To Manufacturers, Not FDA, Pfizer Says

Oct 07 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window